News and Updates
News and Updates
NEWS AND UPDATES
Stay updated with the latest healthcare news
Chose growth over profitability: Core Diagnostics founder on acquisition by Metropolis Healthcare
Core Diagnostics, which started operations in 2012, offers a wide range of diagnostic tests and procedures and was founded "with the mission to make cancer diagnosis accessible for all".
Pune-based startup develops AI-based pulse diagnostic tool for Ayurveda practitioners
A research grant was also received from the Council of Scientific and Industrial Research (CSIR) for this project, said Joshi who founded Atreya Innovations with the support of entrepreneur Anand Deshpande.
IIT Guwahati researchers develop advanced method for Cholesterol and Triglyceride detection
Therefore, timely detection of any abnormality and close monitoring of cholesterol and triglyceride levels in the blood is highly sought. While traditional lipid profile blood tests are reliable, they often require laboratory settings, are not available as a point-of-care solution, and can take time to provide results.
Device maker Stryker strikes $4.9 billion deal for Inari Medical
The deal for Inari bolsters Stryker's efforts to build out its offerings to treat a condition called venous thromboembolism, where a blood clot forms in a vein, and other vascular diseases. Under the terms of the deal, which was first reported by Reuters earlier on Monday, Stryker will pay $80 per share for Inari.
IIT Bombay develops portable, affordable Tinnitus diagnosis, management device
As per the research data published in JAMA Neurology 2022, Tinnitus affects more than 740 million adults globally and is considered to be a major problem faced by more than 120 million people, IIT Bombay said in a statement.
Pulse oximeters may misread oxygen levels in people of color. The FDA wants to change that
The Food and Drug Administration's recommendations apply to pulse oximeters, which are clip-on devices used in hospitals and medical clinics to ensure patients are getting enough oxygen. The FDA said it wants companies to conduct larger studies and include more patients from different racial groups.
Creating a culture of quality in diagnostics: Ensuring accurate reports
In healthcare, lab results guide approximately 70 per cent of medical decisions. When these results are inaccurate or delayed, the consequences can be severe, ranging from misdiagnosis to inappropriate treatments that compromise patient health. By nurturing a culture of quality, labs ensure that their processes—from sample collection to result reporting—are as precise and reliable as possible. This leads to better patient care, greater safety and improved medical outcomes.
India's first Robotic-assisted Paediatric Gait Trainer for physical rehabilitation launched
The G-Gaiter Paediatric integrates advanced Virtual Reality (VR) technology and real-time interactive games, providing an engaging and stimulating therapy experience, the release stated.
Metropolis Healthcare acquires Core Diagnostics to expand cancer diagnostics
Metropolis will acquire a 100 per cent stake in Core Diagnostics through a combination of cash and stock, financing 55per cent of the transaction in cash and 45 per cent through an equity swap, totalling INR 246.8 crores. Core Diagnostics registered revenue of INR 110 crores in FY 2023-24. The equity issuance is subject to shareholder approval, and the acquisition is expected to be completed within 60 days.
Health Ministry turns to other public departments to fill CDSCO workforce gap
The advertised 14 vacancies include one Additional Drugs Controller, four Joint Drugs Controllers, and nine Deputy Drugs Controllers. All positions are classified as Group 'A' Gazetted non-ministerial roles in the Medical Devices Vertical at CDSCO.
Morocco produces Africa's first mpox tests as the continent tries to rely less on imports
Moroccan startup Moldiag began developing mpox tests after the World Health Organization declared the virus a global emergency in August. Africa's Centers for Disease Control and Prevention has reported more than 59,000 mpox cases and 1,164 deaths in 20 countries this year.
US co Intuitive Surgical bets on India growth & talent: CEO Gary S Guthart
Hospitals in India are increasingly adopting robotic-assisted surgeries as it leads to improved clinical outcomes, patient satisfaction and addresses the surgical skill gaps, Guthart said. "The evidence is that robotic-assisted surgery allows the average surgeon to become better and get better results," he said.
Kotak Pre-IPO fund to buy into diagnostic chain Neuberg
Kotak Pre IPO Opportunities Fund is in advanced talks to acquire a 15% stake in Neuberg Diagnostics for approximately Rs 450 crore. Neuberg's chairman, GSK Velu, plans to use the funds for acquisitions and expansion before a potential IPO next year. The diagnostics chain operates in multiple countries and processes millions of patient samples annually.
IIT-Bombay offers painless ‘shock syringe’ alternative to needle
The shock syringe, no bigger than a ballpoint pen, is powered by a micro shock tube system. Using pressurised nitrogen gas, the device generates a rapid microjet of liquid drug, which penetrates the skin at speed double that of a commercial airplane at takeoff. Unlike traditional syringes, which rely on sharp needles, the shock syringe employs the physics of compressed airwaves to deliver medication, ensuring a virtually painless experience.
Agilus introduces Claudin 18.2 test for precise cancer diagnosis
The Claudin 18.2 test is a highly specialized diagnostic tool, offering precise identification of the Claudin 18.2 protein, a crucial biomarker for gastric, pancreatic, and other cancers. By providing precise identification of this biomarker, this test empowers oncologists with critical insights, aiding in the identification of patients eligible for targeted therapies, improving outcomes in cancer treatment, and fostering personalized medicine.
Abbott and DexCom settle glucose monitor patent disputes
The agreement will dismiss all pending cases in courts and patent offices worldwide, along with a provision preventing legal action between the companies for patent and appearance disputes for the next 10 years.
‘Early diagnosis key to fighting pancreatic cancer’
Dr Ramesh Ardhanari, senior consultant & head, department of surgery & surgical gastroenterology, said the five-year survival rate for pancreatic cancer remains staggeringly low at 12%. Around 1,200 people are diagnosed with this cancer every day worldwide, he said.
MoS Health Anupriya Patel highlights growth potential of India's medical device sector
Addressing the plenary session on "Charting India's MedTech Revolution: MedTech Expansion Roadmap to 2047", she said, "The medical device sector in India is recognised as a sunrise sector because of its immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support and emerging market opportunities."
Suraksha Diagnostic is doing well, peers doing even better
The company is going to enhance revenues by forging more B2B corporate partnerships and increasing medical consultation services through polyclinic chambers at its diagnostic centres. It intends to expand beyond its core markets in adjacent geographies of eastern and north-eastern India. It will supplement organic growth with selective acquisitions.
Par Panel flags gaps in medical radiation device testing oversight
The National Testing House (NTH) currently lacks the expertise and capacity to comprehensively test and certify radiation-emitting medical devices, despite existing regulatory oversight from the Atomic Energy Regulatory Board (AERB) and the Central Drugs Standard Control Organization (CDSCO).
Molbio Diagnostics appoints Professor (Dr) Balram Bhargava, Dr Arun Kumar Jha as independent directors to its board
Professor (Dr) Bhargava is a leader in the public health sector with over 35 years of experience in medical research and health system strengthening. His previous roles include Director-General of the Indian Council of Medical Research and Secretary of India’s Department of Health Research, being at the forefront of managing several public health crises in India. Dr Kumar Jha brings a wealth of experience in public health and policy, including his role as an Adviser in the Department of Economic Affairs, Ministry of Finance, and as an Economic Adviser in the Department of Health & Family Welfare, Ministry of Health & Family Welfare.
64 PHCs in Dakshina Kannada to get ECG machines
The 64 ECG machines, sponsored by Mangalore Refinery and Petrochemicals Limited (MRPL) under its Arogya Samrakshan CSR initiative, aim to strengthen healthcare infrastructure, particularly in rural areas.
US EP diagnostic Catheter market set for 10% CAGR growth
Electrophysiology diagnostic catheters are used to detect and manage arrhythmias, irregular heart rhythms commonly associated with an ageing population and lifestyle factors such as hypertension, obesity, and physical inactivity.
Boston Scientific targeting weight loss market, launches ESG & IGB options
The launched technology Apollo ESG System is authorised by both US FDA and CDSCO while, Orbera365 System is indicated by CDSCO for temporary usage on those obese patients (BMI 30-50) who failed to achieve and maintain weight loss with a supervised weight-control program.
HCG Teams Up with Trucan for cutting-edge cancer detection and therapy monitoring
These tests leverage advanced techniques, including next-generation sequencing and biomarker-driven diagnostics, to enable precise detection of primary, recurrent, and metastatic cancers, predict therapy response before treatment, and monitor patients undergoing chemotherapy or targeted therapy.
AVEIR VR pacemaker delivers customisable programming: Prof. Antonio Curnis
Prof. Curnis highlights the significant impact of minimally invasive technologies while discussing the global challenges and opportunities in managing heart failure.
Singapore launches telehealth platform for diabetes management
Traditional diabetes management methods, such as glucose meters and insulin therapy, have notable limitations, including delayed treatment adjustments and a lack of real-time monitoring. These challenges contribute to less effective control of the condition.
SS Innovations Surgical Robot system gets CDSCO approval
The central regulator has granted its approval for telesurgery & teleproctoring and The robotic technology is a modular multi-arm system which allows for the use of 3-5 robotic arms and has an open-faced ergonomic Surgeon Command Centre and the central regulator has granted its approval for its usage in telesurgery & teleproctoring.
Treatment, lab charges hiked 20% in govt medical college hospitals in Karnataka
The increased charges took effect recently in hospitals coming under the Bangalore Medical College and Research Institute (BMCRI) and various other autonomous medical education institutions elsewhere in the state. This was confirmed by Dr BL Sujatha Rathod, director of medical education.
‘Wearable cardio devices play crucial role in mgmt of heart’
These devices, including advanced smartwatches and chest-mounted sensors, are set to enhance detection, monitoring, and management of heart health through innovative methods. This was the key focus on the third day of the Cardiological Society of India conference on Saturday.
Cinven secures Italian nod to sell minority stake in Synlab to Labcorp
Golden powers legislation requires Italian government approval for any decision which results in changes in the ownership, control or availability of strategic assets in the country.
MMDP kits distributed to filariasis patients
The MDMP kit comprises a bucket, mug, towel, tub, soap and cream. The beneficiaries received guidance regarding cream application for cuts or infections on the affected area. Daily adherence to this regimen safeguards the affected organs and provides relief. Additionally, patients must perform daily exercises whilst standing on their heels.
Diagnosed prevalent cases of type 1 diabetes to reach 3.166 mn in 2033: GlobalData
According to GlobalData epidemiologists, the US had the highest number of diagnosed prevalent cases of T1D in 2023 with 1.77 million in 2023, whereas Japan had the lowest number of prevalent cases at 120,000.
CHC Tripuri gets state-of-art ultrasound machine worth Rs 25 lakh
Dr Balbir Singh highlighted that chief minister Bhagwant Mann has approved the upgradation and expansion of CHC Tripuri. The hospital will soon undergo a facelift, including the addition of a new floor, operational lifts, and renovated bathrooms. He assured that these improvements will be completed within two months.
GMC to launch skull-base surgery unit
He said that the unit will function under the department of neurosurgery and the department of ear, nose, and throat (ENT). It will be led by consultant ENT surgeon at Bombay Hospital, Nishit Shah, and H N Reliance Mumbai, alongside head of the neurosurgery department at GMC, Ponraj Sundaram.
Medtronic introduces Percept RC neurostimulator in India after FDA approval
The Percept™ neurostimulators are equipped with sensing capabilities that help doctors provide tailored treatments for conditions like Parkinson's disease, essential tremor, dystonia, and epilepsy.
Apollo Radiology International acquires UK-based InHealth Limited
ARI is projected to report over two million scans annually, spanning 24 countries and serving more than 200 healthcare organizations. Through this acquisition, ARI aims to expand its reporting services across a broader network of NHS partners in the UK.
Milestone for India: Indigenous E-beam technology sterilises 50 lakh medical devices
To make the memory of this moment everlasting, RR-CAT Director Unmesh D Malshe presented a memento to Mohanty, the official added. According to the official, the facility to sterilize medical devices in this unit started in October 2022 and so far 50 lakh medical devices of different companies have been sterilized in it.
Integrated diagnostics powered by genomics set to transform India’s healthcare landscape in the next 5-7 years
Genomic tests, now becoming as routine as pathology and imaging, are poised to enhance early detection of both communicable and non-communicable diseases. The integration of AI, machine learning, and affordable diagnostic platforms will play a key role in democratizing healthcare, ensuring access to high-quality diagnostic services even in Tier 3 cities. Collaborations with private and government insurance schemes, like Ayushman Bharat, will further propel this transformation, making genomic screening a part of primary healthcare.
Ficci seeks govt nod to restart import of pre-owned expensive medical equipment
Industry chamber Ficci has urged the government to permit the import of pre-owned and refurbished high-end medical equipment. Previously facilitated with a no objection certificate, such imports have stalled since August 15 due to new registration requirements with the Central Drugs Standard Control Organization (CDSCO), which currently lacks provisions for refurbished equipment.
NEWS AND UPDATES
Stay updated with the latest healthcare news
Chose growth over profitability: Core Diagnostics founder on acquisition by Metropolis Healthcare
Core Diagnostics, which started operations in 2012, offers a wide range of diagnostic tests and procedures and was founded "with the mission to make cancer diagnosis accessible for all".
Pune-based startup develops AI-based pulse diagnostic tool for Ayurveda practitioners
A research grant was also received from the Council of Scientific and Industrial Research (CSIR) for this project, said Joshi who founded Atreya Innovations with the support of entrepreneur Anand Deshpande.
IIT Guwahati researchers develop advanced method for Cholesterol and Triglyceride detection
Therefore, timely detection of any abnormality and close monitoring of cholesterol and triglyceride levels in the blood is highly sought. While traditional lipid profile blood tests are reliable, they often require laboratory settings, are not available as a point-of-care solution, and can take time to provide results.
Device maker Stryker strikes $4.9 billion deal for Inari Medical
The deal for Inari bolsters Stryker's efforts to build out its offerings to treat a condition called venous thromboembolism, where a blood clot forms in a vein, and other vascular diseases. Under the terms of the deal, which was first reported by Reuters earlier on Monday, Stryker will pay $80 per share for Inari.
IIT Bombay develops portable, affordable Tinnitus diagnosis, management device
As per the research data published in JAMA Neurology 2022, Tinnitus affects more than 740 million adults globally and is considered to be a major problem faced by more than 120 million people, IIT Bombay said in a statement.
Pulse oximeters may misread oxygen levels in people of color. The FDA wants to change that
The Food and Drug Administration's recommendations apply to pulse oximeters, which are clip-on devices used in hospitals and medical clinics to ensure patients are getting enough oxygen. The FDA said it wants companies to conduct larger studies and include more patients from different racial groups.
Creating a culture of quality in diagnostics: Ensuring accurate reports
In healthcare, lab results guide approximately 70 per cent of medical decisions. When these results are inaccurate or delayed, the consequences can be severe, ranging from misdiagnosis to inappropriate treatments that compromise patient health. By nurturing a culture of quality, labs ensure that their processes—from sample collection to result reporting—are as precise and reliable as possible. This leads to better patient care, greater safety and improved medical outcomes.
India's first Robotic-assisted Paediatric Gait Trainer for physical rehabilitation launched
The G-Gaiter Paediatric integrates advanced Virtual Reality (VR) technology and real-time interactive games, providing an engaging and stimulating therapy experience, the release stated.
Metropolis Healthcare acquires Core Diagnostics to expand cancer diagnostics
Metropolis will acquire a 100 per cent stake in Core Diagnostics through a combination of cash and stock, financing 55per cent of the transaction in cash and 45 per cent through an equity swap, totalling INR 246.8 crores. Core Diagnostics registered revenue of INR 110 crores in FY 2023-24. The equity issuance is subject to shareholder approval, and the acquisition is expected to be completed within 60 days.
Health Ministry turns to other public departments to fill CDSCO workforce gap
The advertised 14 vacancies include one Additional Drugs Controller, four Joint Drugs Controllers, and nine Deputy Drugs Controllers. All positions are classified as Group 'A' Gazetted non-ministerial roles in the Medical Devices Vertical at CDSCO.
Morocco produces Africa's first mpox tests as the continent tries to rely less on imports
Moroccan startup Moldiag began developing mpox tests after the World Health Organization declared the virus a global emergency in August. Africa's Centers for Disease Control and Prevention has reported more than 59,000 mpox cases and 1,164 deaths in 20 countries this year.
US co Intuitive Surgical bets on India growth & talent: CEO Gary S Guthart
Hospitals in India are increasingly adopting robotic-assisted surgeries as it leads to improved clinical outcomes, patient satisfaction and addresses the surgical skill gaps, Guthart said. "The evidence is that robotic-assisted surgery allows the average surgeon to become better and get better results," he said.
Kotak Pre-IPO fund to buy into diagnostic chain Neuberg
Kotak Pre IPO Opportunities Fund is in advanced talks to acquire a 15% stake in Neuberg Diagnostics for approximately Rs 450 crore. Neuberg's chairman, GSK Velu, plans to use the funds for acquisitions and expansion before a potential IPO next year. The diagnostics chain operates in multiple countries and processes millions of patient samples annually.
IIT-Bombay offers painless ‘shock syringe’ alternative to needle
The shock syringe, no bigger than a ballpoint pen, is powered by a micro shock tube system. Using pressurised nitrogen gas, the device generates a rapid microjet of liquid drug, which penetrates the skin at speed double that of a commercial airplane at takeoff. Unlike traditional syringes, which rely on sharp needles, the shock syringe employs the physics of compressed airwaves to deliver medication, ensuring a virtually painless experience.
Agilus introduces Claudin 18.2 test for precise cancer diagnosis
The Claudin 18.2 test is a highly specialized diagnostic tool, offering precise identification of the Claudin 18.2 protein, a crucial biomarker for gastric, pancreatic, and other cancers. By providing precise identification of this biomarker, this test empowers oncologists with critical insights, aiding in the identification of patients eligible for targeted therapies, improving outcomes in cancer treatment, and fostering personalized medicine.
Abbott and DexCom settle glucose monitor patent disputes
The agreement will dismiss all pending cases in courts and patent offices worldwide, along with a provision preventing legal action between the companies for patent and appearance disputes for the next 10 years.
‘Early diagnosis key to fighting pancreatic cancer’
Dr Ramesh Ardhanari, senior consultant & head, department of surgery & surgical gastroenterology, said the five-year survival rate for pancreatic cancer remains staggeringly low at 12%. Around 1,200 people are diagnosed with this cancer every day worldwide, he said.
MoS Health Anupriya Patel highlights growth potential of India's medical device sector
Addressing the plenary session on "Charting India's MedTech Revolution: MedTech Expansion Roadmap to 2047", she said, "The medical device sector in India is recognised as a sunrise sector because of its immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support and emerging market opportunities."
Suraksha Diagnostic is doing well, peers doing even better
The company is going to enhance revenues by forging more B2B corporate partnerships and increasing medical consultation services through polyclinic chambers at its diagnostic centres. It intends to expand beyond its core markets in adjacent geographies of eastern and north-eastern India. It will supplement organic growth with selective acquisitions.
Par Panel flags gaps in medical radiation device testing oversight
The National Testing House (NTH) currently lacks the expertise and capacity to comprehensively test and certify radiation-emitting medical devices, despite existing regulatory oversight from the Atomic Energy Regulatory Board (AERB) and the Central Drugs Standard Control Organization (CDSCO).
Molbio Diagnostics appoints Professor (Dr) Balram Bhargava, Dr Arun Kumar Jha as independent directors to its board
Professor (Dr) Bhargava is a leader in the public health sector with over 35 years of experience in medical research and health system strengthening. His previous roles include Director-General of the Indian Council of Medical Research and Secretary of India’s Department of Health Research, being at the forefront of managing several public health crises in India. Dr Kumar Jha brings a wealth of experience in public health and policy, including his role as an Adviser in the Department of Economic Affairs, Ministry of Finance, and as an Economic Adviser in the Department of Health & Family Welfare, Ministry of Health & Family Welfare.
64 PHCs in Dakshina Kannada to get ECG machines
The 64 ECG machines, sponsored by Mangalore Refinery and Petrochemicals Limited (MRPL) under its Arogya Samrakshan CSR initiative, aim to strengthen healthcare infrastructure, particularly in rural areas.
US EP diagnostic Catheter market set for 10% CAGR growth
Electrophysiology diagnostic catheters are used to detect and manage arrhythmias, irregular heart rhythms commonly associated with an ageing population and lifestyle factors such as hypertension, obesity, and physical inactivity.
Boston Scientific targeting weight loss market, launches ESG & IGB options
The launched technology Apollo ESG System is authorised by both US FDA and CDSCO while, Orbera365 System is indicated by CDSCO for temporary usage on those obese patients (BMI 30-50) who failed to achieve and maintain weight loss with a supervised weight-control program.
HCG Teams Up with Trucan for cutting-edge cancer detection and therapy monitoring
These tests leverage advanced techniques, including next-generation sequencing and biomarker-driven diagnostics, to enable precise detection of primary, recurrent, and metastatic cancers, predict therapy response before treatment, and monitor patients undergoing chemotherapy or targeted therapy.
AVEIR VR pacemaker delivers customisable programming: Prof. Antonio Curnis
Prof. Curnis highlights the significant impact of minimally invasive technologies while discussing the global challenges and opportunities in managing heart failure.
Singapore launches telehealth platform for diabetes management
Traditional diabetes management methods, such as glucose meters and insulin therapy, have notable limitations, including delayed treatment adjustments and a lack of real-time monitoring. These challenges contribute to less effective control of the condition.
SS Innovations Surgical Robot system gets CDSCO approval
The central regulator has granted its approval for telesurgery & teleproctoring and The robotic technology is a modular multi-arm system which allows for the use of 3-5 robotic arms and has an open-faced ergonomic Surgeon Command Centre and the central regulator has granted its approval for its usage in telesurgery & teleproctoring.
Treatment, lab charges hiked 20% in govt medical college hospitals in Karnataka
The increased charges took effect recently in hospitals coming under the Bangalore Medical College and Research Institute (BMCRI) and various other autonomous medical education institutions elsewhere in the state. This was confirmed by Dr BL Sujatha Rathod, director of medical education.
‘Wearable cardio devices play crucial role in mgmt of heart’
These devices, including advanced smartwatches and chest-mounted sensors, are set to enhance detection, monitoring, and management of heart health through innovative methods. This was the key focus on the third day of the Cardiological Society of India conference on Saturday.
Cinven secures Italian nod to sell minority stake in Synlab to Labcorp
Golden powers legislation requires Italian government approval for any decision which results in changes in the ownership, control or availability of strategic assets in the country.
MMDP kits distributed to filariasis patients
The MDMP kit comprises a bucket, mug, towel, tub, soap and cream. The beneficiaries received guidance regarding cream application for cuts or infections on the affected area. Daily adherence to this regimen safeguards the affected organs and provides relief. Additionally, patients must perform daily exercises whilst standing on their heels.
Diagnosed prevalent cases of type 1 diabetes to reach 3.166 mn in 2033: GlobalData
According to GlobalData epidemiologists, the US had the highest number of diagnosed prevalent cases of T1D in 2023 with 1.77 million in 2023, whereas Japan had the lowest number of prevalent cases at 120,000.
CHC Tripuri gets state-of-art ultrasound machine worth Rs 25 lakh
Dr Balbir Singh highlighted that chief minister Bhagwant Mann has approved the upgradation and expansion of CHC Tripuri. The hospital will soon undergo a facelift, including the addition of a new floor, operational lifts, and renovated bathrooms. He assured that these improvements will be completed within two months.
GMC to launch skull-base surgery unit
He said that the unit will function under the department of neurosurgery and the department of ear, nose, and throat (ENT). It will be led by consultant ENT surgeon at Bombay Hospital, Nishit Shah, and H N Reliance Mumbai, alongside head of the neurosurgery department at GMC, Ponraj Sundaram.
Medtronic introduces Percept RC neurostimulator in India after FDA approval
The Percept™ neurostimulators are equipped with sensing capabilities that help doctors provide tailored treatments for conditions like Parkinson's disease, essential tremor, dystonia, and epilepsy.
Apollo Radiology International acquires UK-based InHealth Limited
ARI is projected to report over two million scans annually, spanning 24 countries and serving more than 200 healthcare organizations. Through this acquisition, ARI aims to expand its reporting services across a broader network of NHS partners in the UK.
Milestone for India: Indigenous E-beam technology sterilises 50 lakh medical devices
To make the memory of this moment everlasting, RR-CAT Director Unmesh D Malshe presented a memento to Mohanty, the official added. According to the official, the facility to sterilize medical devices in this unit started in October 2022 and so far 50 lakh medical devices of different companies have been sterilized in it.
Integrated diagnostics powered by genomics set to transform India’s healthcare landscape in the next 5-7 years
Genomic tests, now becoming as routine as pathology and imaging, are poised to enhance early detection of both communicable and non-communicable diseases. The integration of AI, machine learning, and affordable diagnostic platforms will play a key role in democratizing healthcare, ensuring access to high-quality diagnostic services even in Tier 3 cities. Collaborations with private and government insurance schemes, like Ayushman Bharat, will further propel this transformation, making genomic screening a part of primary healthcare.
Ficci seeks govt nod to restart import of pre-owned expensive medical equipment
Industry chamber Ficci has urged the government to permit the import of pre-owned and refurbished high-end medical equipment. Previously facilitated with a no objection certificate, such imports have stalled since August 15 due to new registration requirements with the Central Drugs Standard Control Organization (CDSCO), which currently lacks provisions for refurbished equipment.